2m 2m 2m 2m 2m 2m 2m
STEV GRP (STVN)
NYSE
$16.85-$0.09 (-0.53%)
Price as of Jun 23, 2026 4:10 PM EDT- $840.3MMarket Cap
- -27.47%1-Year Change
- Medical Instruments & SuppliesIndustry
STEV GRP (STVN)
$16.85-$0.09 (-0.53%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B +7.45% | 1.1B +1.72% | 1.1B +10.34% | 983.7M +16.56% | |
Cost of Revenue | 842.4M +5.08% | 801.7M +7.55% | 745.5M +12.29% | 663.9M +14.76% | |
Gross Profit | 343.9M +13.75% | 302.3M -11.05% | 339.9M +6.28% | 319.8M +20.50% | |
Sales and Marketing Expense | 28.2M +13.54% | 24.9M -0.50% | 25.0M -4.25% | 26.1M +27.57% | |
Research and Development Expense | -25.4M -19.68% | -31.7M -11.22% | -35.7M +3.74% | -34.4M +16.11% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 99.7M +6.31% | 93.7M +5.40% | 88.9M +3.73% | 85.7M +37.19% | |
Operating Profit | 198.8M +23.37% | 161.1M -19.72% | 200.7M +4.31% | 192.4M +18.62% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -5.6M -7.93% | -6.1M +63.50% | -3.7M +11.03% | -3.4M -21.54% | |
Interest Income and Expense and Net | -5.6M -7.93% | -6.1M +63.50% | -3.7M +11.03% | -3.4M -21.54% | |
Total Nonoperating Income and Expense | 5.6M -7.93% | 6.1M +63.50% | 3.7M +11.03% | 3.4M -21.54% | |
Income before Taxes | 139.8M +18.74% | 117.8M -19.17% | 145.7M +1.87% | 143.0M +6.51% | |
Income Taxes | 49.3M +15.88% | 42.5M -3.06% | 43.9M -1.71% | 44.6M +42.10% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 139.8M +18.74% | 117.8M -19.17% | 145.7M +1.87% | 143.0M +6.51% | |
Net Income from Continuing Operations Applicable to Common | 139.8M +18.74% | 117.8M -19.17% | 145.7M +1.87% | 143.0M +6.51% | |
Basic EPS and Net Income | 0.51 +18.60% | 0.43 -21.82% | 0.55 +1.85% | 0.54 +1.89% | |
Diluted EPS and Net Income | 0.51 +18.60% | 0.43 -21.82% | 0.55 +1.85% | 0.54 +1.89% | |
Basic Weighted Average Shares | 273.0M +0.67% | 271.1M +2.33% | 265.0M +0.10% | 264.7M +4.76% | |
Diluted Weighted Average Shares | 273.0M +0.67% | 271.1M +2.33% | 265.0M +0.10% | 264.7M +4.76% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 130.6M +32.90% | 98.3M +41.19% | 69.6M -69.57% | 228.7M -44.35% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 130.6M +32.90% | 98.3M +41.19% | 69.6M -69.57% | 228.7M -44.35% | |
Total Current Assets | 943.4M +7.18% | 880.1M +2.12% | 861.9M +1.91% | 845.8M -2.33% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.4B +11.47% | 1.2B +21.38% | 1.0B +60.35% | 641.4M +63.32% | |
Total Long-Term Assets | 1.6B +10.49% | 1.4B +19.76% | 1.2B +48.62% | 813.9M +47.22% | |
Total Assets | 2.5B +9.24% | 2.3B +12.42% | 2.1B +24.82% | 1.7B +16.98% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 535.9M +12.23% | 477.5M -16.87% | 574.4M +24.19% | 462.5M +36.58% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 521.6M +16.69% | 447.0M +22.61% | 364.5M +81.11% | 201.3M -15.62% | |
Total Liabilities | 1.1B +14.39% | 924.4M -1.54% | 938.9M +41.45% | 663.8M +15.00% | |
Retained Earnings | 736.9M +12.86% | 653.0M +20.33% | 542.7M +24.50% | 435.9M +42.04% | |
Total Stockholders Equity | 1.5B +5.85% | 1.4B +23.99% | 1.1B +13.73% | 995.9M +18.33% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 286.1M +83.65% | 155.8M +48.06% | 105.2M +1.84% | 103.3M -22.52% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -272.9M -12.02% | -310.2M -26.35% | -421.2M +73.38% | -242.9M +151.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 22.1M -87.96% | 183.2M +15.94% | 158.0M +454.84% | -44.5M -117.48% | |
Financials Ratio | |||||
Gross Margin | 28.99% +5.86% | 27.38% -12.56% | 31.32% -3.67% | 32.51% N/A | |
Operating Margin | 16.76% +14.82% | 14.60% -21.08% | 18.49% -5.46% | 19.56% N/A | |
Return on Assets | 5.74% +7.23% | 5.35% -31.46% | 7.81% -15.95% | 9.29% N/A | |
Return on Equity | 9.67% +4.20% | 9.28% -32.18% | 13.69% -12.06% | 15.57% N/A | |
Revenue Growth | 7.45% +332.79% | 1.72% -83.35% | 10.34% -37.59% | 16.56% N/A | |
Current Ratio | 1.76 -4.50% | 1.84 +22.85% | 1.50 -17.95% | 1.83 N/A | |
Cash Ratio | 0.24 +18.42% | 0.21 +69.80% | 0.12 -75.50% | 0.49 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow